首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Anemia management trends in patients on peritoneal dialysis in the past 10 years
【2h】

Anemia management trends in patients on peritoneal dialysis in the past 10 years

机译:过去10年腹膜透析患者的贫血管理趋势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: This study is to investigate anemia management trends in patients on peritoneal dialysis in Huashan Hospital in the past 10 years. Methods: A total of 463 cases of patients receiving peritoneal dialysis from July 2004 to March 2014 were analyzed retrospectively. The patients enrolled in this study all were elder than 18 years old, those who had been followed up for at least 1 quarter. Clinical data of anemia including hemoglobin, serum iron, iron saturation, dosage of erythropoietin (EPO) and iron supplements were collected quarterly and then analyzed those data. Results: In the first period of 25 quarters, in a certain range, increased dose of erythropoietin and iron content, can make the patient’s hemoglobin gradually increased to the ideal level, which helps to treat the symptoms of anemia patients. Results of comparation before and after the education program showed that with the enhance the EPO injection compliance and treat anemia with the proper dose of EPO, the PD patients have stable level of Hemoglobin, accompanying with the decreased dose of oral Iron and intravenous iron. Conclusion: It was shown that hemoglobin value was constantly stable. Treat anemia with proper dose of EPO individually could cure anemia effectively with the reducing of iron supplement improvement peritoneal dialysis patients’ anemia related knowledge, and the good compliance of injection of EPO, serum iron and iron saturation could still keep stable, although declined intake of iron supplements. Therefore, optimizing anemia management in peritoneal dialysis patients is helpful to improve their quality of life.
机译:目的:探讨华山医院近10年来腹膜透析患者的贫血管理趋势。方法:回顾性分析2004年7月至2014年3月收治的463例腹膜透析患者。参加本研究的患者均年龄在18岁以上,接受了至少四分之一的随访。每季度收集贫血的临床数据,包括血红蛋白,血清铁,铁饱和度,促红细胞生成素(EPO)剂量和铁补充剂,然后对这些数据进行分析。结果:在最初25个季度的一定范围内,增加促红细胞生成素的剂量和铁含量,可使患者的血红蛋白逐渐增加至理想水平,从而有助于治疗贫血患者的症状。教育计划前后的比较结果表明,随着EPO注射依从性的提高和适当剂量的EPO治疗贫血,PD患者的血红蛋白水平稳定,同时口服铁和静脉注射铁的剂量减少。结论:显示血红蛋白值一直稳定。单独使用适当剂量的EPO治疗贫血可以通过减少铁补充剂改善腹膜透析患者贫血的相关知识来有效治愈贫血,尽管EPO的摄入减少,但注射EPO,血清铁和铁饱和度的良好依从性仍能保持稳定铁补充剂。因此,优化腹膜透析患者的贫血管理有助于改善他们的生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号